These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15069698)

  • 1. Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)amino- methyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells.
    Zhang Y; Adachi M; Zhao X; Kawamura R; Imai K
    Int J Cancer; 2004 Jun; 110(2):301-8. PubMed ID: 15069698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of histone deacetylase inhibitors FK228 and m-carboxycinnamic acid bis-hydroxamide with proteasome inhibitors PSI and PS-341 against gastrointestinal adenocarcinoma cells.
    Adachi M; Zhang Y; Zhao X; Minami T; Kawamura R; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Jun; 10(11):3853-62. PubMed ID: 15173094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors enhance phosphorylation of histone H2AX after ionizing radiation.
    Zhang Y; Adachi M; Zou H; Hareyama M; Imai K; Shinomura Y
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):859-66. PubMed ID: 16751067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bmf contributes to histone deacetylase inhibitor-mediated enhancing effects on apoptosis after ionizing radiation.
    Zhang Y; Adachi M; Kawamura R; Zou HC; Imai K; Hareyama M; Shinomura Y
    Apoptosis; 2006 Aug; 11(8):1349-57. PubMed ID: 16830229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bmf is a possible mediator in histone deacetylase inhibitors FK228 and CBHA-induced apoptosis.
    Zhang Y; Adachi M; Kawamura R; Imai K
    Cell Death Differ; 2006 Jan; 13(1):129-40. PubMed ID: 15947789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo.
    Sawa H; Murakami H; Kumagai M; Nakasato M; Yamauchi S; Matsuyama N; Tamura Y; Satone A; Ide W; Hashimoto I; Kamada H
    Acta Neuropathol; 2004 Jun; 107(6):523-31. PubMed ID: 15024582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation.
    Kawano T; Akiyama M; Agawa-Ohta M; Mikami-Terao Y; Iwase S; Yanagisawa T; Ida H; Agata N; Yamada H
    Int J Oncol; 2010 Oct; 37(4):787-95. PubMed ID: 20811699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of angiogenesis factors.
    Sasakawa Y; Naoe Y; Noto T; Inoue T; Sasakawa T; Matsuo M; Manda T; Mutoh S
    Biochem Pharmacol; 2003 Sep; 66(6):897-906. PubMed ID: 12963476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib.
    Sutheesophon K; Kobayashi Y; Takatoku MA; Ozawa K; Kano Y; Ishii H; Furukawa Y
    Acta Haematol; 2006; 115(1-2):78-90. PubMed ID: 16424655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
    Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
    Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor FK228 suppresses the Ras-MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma.
    Kobayashi Y; Ohtsuki M; Murakami T; Kobayashi T; Sutheesophon K; Kitayama H; Kano Y; Kusano E; Nakagawa H; Furukawa Y
    Oncogene; 2006 Jan; 25(4):512-24. PubMed ID: 16186804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of FK228, a novel histone deacetylase inhibitor, on tumor growth and expression of p21 and c-myc genes in vivo.
    Sasakawa Y; Naoe Y; Inoue T; Sasakawa T; Matsuo M; Manda T; Mutoh S
    Cancer Lett; 2003 Jun; 195(2):161-8. PubMed ID: 12767524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of radiation response by histone deacetylase inhibition.
    Chinnaiyan P; Vallabhaneni G; Armstrong E; Huang SM; Harari PM
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):223-9. PubMed ID: 15850925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells.
    Hoshino I; Matsubara H; Hanari N; Mori M; Nishimori T; Yoneyama Y; Akutsu Y; Sakata H; Matsushita K; Seki N; Ochiai T
    Clin Cancer Res; 2005 Nov; 11(21):7945-52. PubMed ID: 16278420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK228 sensitizes radioresistant small cell lung cancer cells to radiation.
    Li H; Ma L; Bian X; Lv Y; Lin W
    Clin Epigenetics; 2021 Feb; 13(1):41. PubMed ID: 33632300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of extracellular signal-regulated kinase activation in human osteosarcoma cell resistance to the histone deacetylase inhibitor FK228 [(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone].
    Matsubara H; Watanabe M; Imai T; Yui Y; Mizushima Y; Hiraumi Y; Kamitsuji Y; Watanabe K; Nishijo K; Toguchida J; Nakahata T; Adachi S
    J Pharmacol Exp Ther; 2009 Mar; 328(3):839-48. PubMed ID: 19073909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Hybrid-polar Histone Deacetylase Inhibitor m-Carboxycinnamic Acid bis-Hydroxyamide on Human Pancreatic Adenocarcinoma Cells.
    Kumar D; Sarma P; Bhadra MP; Tangutur AD
    Anticancer Agents Med Chem; 2019; 19(6):750-759. PubMed ID: 30621566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation.
    Camphausen K; Scott T; Sproull M; Tofilon PJ
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6066-71. PubMed ID: 15447991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models.
    Sasaki Y; Negishi H; Idogawa M; Suzuki H; Mita H; Toyota M; Shinomura Y; Imai K; Tokino T
    Mol Cancer Ther; 2008 Apr; 7(4):779-87. PubMed ID: 18413792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
    Baradari V; Huether A; Höpfner M; Schuppan D; Scherübl H
    Endocr Relat Cancer; 2006 Dec; 13(4):1237-50. PubMed ID: 17158768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.